US Archives - Page 45 of 223 - European Medical Journal

Pregnant woman in a calm home setting reflecting on anxiety in pregnancy and virtual mental health support.

Brief Virtual Therapy May Ease Anxiety in Pregnancy

Brief virtual therapy for anxiety in pregnancy was feasible, well accepted, and linked to reduced symptoms.

What’s New in Targeted Therapy for Chronic Inflammatory Skin Disease?

Catch up on selected 2025-2026 conference data across AD, CHE, GPP, and PG, including symptom burden, long-term disease impact, and…

Waiting room at a sexual health clinic, with several adults seated in a row while a patient checks in at reception.

Longitudinal Sampling in Sexually Transmitted Enteric Infections

Longitudinal sampling for sexually transmitted enteric infections appeared feasible among GBMSM attending sexual health services.

Little girl holding an asthma inhaler.

Why Severe Childhood Asthma Persists Globally

Severe childhood asthma continues to cause major morbidity in low- and middle-income countries despite its low prevalence.

31 Mar 2026

The Role of Muscle in SMA

This interactive infographic explains the role of muscle and motor neurons in the trajectory of spinal muscular atrophy, and considers…

31 Mar 2026

Rethinking Early Intervention in Relapsing MS

Interactive expert-led article addresses common concerns that limit safety confidence and reduce treatment utilization…

AMJ Dermatology 3 [Supplement 1] 2026

Catch up on selected 2025-2026 conference data across AD, CHE, GPP, and PG, including symptom burden, long-term disease impact, and…

mid adult man with alopecia looking at mirror, hair loss concept

Cell-Free Hair Loss Therapy Spurs Regrowth

Cell-free secretome therapy restored hair growth in preclinical androgenic alopecia models by protecting papilla cells.

Elderly woman with back pain examined by doctor in medical clinic.

Arthralgia Criteria Improves Rheumatoid Arthritis Prediction

Rheumatoid arthritis risk criteria may help identify which patients with arthralgia are most likely to progress.

Patient with alopecia areata in consultation with a healthcare professional

AAD 2026: Strong Week 24 Outcomes in Severe Alopecia Areata

Patients with severe alopecia areata treated with upadacitinib achieved greater hair regrowth at Week 24 versus placebo.